IA
MXCT icon

IFP Advisors’s MaxCyte MXCT Stock Holding History

IFP Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812 Buy
660
+54
+9% +$54 ﹤0.01% 4565
2026
Q1 		$426 Buy
606
+585
+2,786% +$546 ﹤0.01% 4455
2025
Q4 		$33 Sell
21
-1
-5% -$2 ﹤0.01% 4752
2025
Q3 		$35 Sell
22
-34
-61% -$59 ﹤0.01% 4701
2025
Q2 		$121 Buy
56
+22
+65% +$53 ﹤0.01% 4710
2025
Q1 		$93 Sell
34
-26
-43% -$103 ﹤0.01% 3868
2024
Q4 		$249 Buy
+60
New +$227 ﹤0.01% 3631

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

IFP Advisors's MXCT Position: Q2 2026 in Review

IFP Advisors increased its MaxCyte (MXCT) stake by 8.9% in Q2 2026, buying an estimated $54 and bringing the position to 660 shares worth $812. The position accounts for ﹤0.01% of the portfolio, ranked #4565.

IFP Advisors first reported a position in MXCT in Q4 2024 and has held it in 7 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • IFP Advisors held 660 shares of MaxCyte worth $812 as of Q2 2026.
  • IFP Advisors bought 54 MaxCyte shares in Q2 2026, an estimated $54.
  • MaxCyte made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4565 holding.
  • IFP Advisors first reported a position in MaxCyte in Q4 2024 and has held it in 7 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.